The Invesco Perpetual UK Growth Fund aims to achieve capital growth in the UK.
Name | % Net Assets |
---|---|
GlaxoSmithKline | 7.7% |
BG | 6.2% |
Royal Dutch Shell ''A'' (UK list) | 5.7% |
BP | 5.6% |
BT | 5.0% |
AstraZeneca | 4.9% |
Vodafone | 4.8% |
Imperial Tobacco | 4.5% |
National Grid | 3.9% |
Rolls-Royce | 3.1% |
Key | % Net Assets |
---|---|
GlaxoSmithKline | 7.7% |
BG | 6.2% |
Royal Dutch Shell ''A'' (UK list) | 5.7% |
BP | 5.6% |
Other | 74.8% |
Date | 21-Nov-2024 |
---|---|
NAV | 280.58p |
Currency | GBP |
Change | 0.14p |
% | 0.05% |
YTD change | 26.62p |
YTD % | 10.48% |
Fund Inception | 12/06/1987 |
---|---|
Fund Manager | Ed Burke |
TER | 1.19 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.16% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research